New research out of Stanford helps reveal why some people infected with SARS-CoV-2 experience mild COVID symptoms while others experience a severe clinical course.
What is really exciting is that this research reveals immune targets that we can take action toward optimizing in order to prevent infection and/or optimize recovery if infected.
